United Therapeutics (UTHR) Operating Income (2009 - 2026)
United Therapeutics' Operating Income was $330.8 million in Q2 2026, down 9.2% from $364.5 million a year earlier but up 1.5% from the prior quarter.
Powered by 
Analysis
United Therapeutics (UTHR) Operating Income (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, United Therapeutics' Operating Income was $1.4 billion through Jun 30, 2026, down 3.2% year-over-year; for FY2025, it was $1.49 billion, up 8.4% from FY2024.
- Operating Income has now increased for four consecutive years, with a five-year compound annual growth rate of 20.2% (FY2020 to FY2025).
- In earlier years, Operating Income was $1.38 billion in FY2024 (+16.2%), $1.18 billion in FY2023 (+20.9%), $979.7 million in FY2022 (+76.2%) and $555.9 million in FY2021 (-6.4%).
- Quarterly Operating Income has moved between $169.8 million (Q4 2021) and $388.5 million (Q3 2025) over five years.
- Compared with a year earlier, Operating Income has declined for three straight quarters, with growth averaging 6.6% over the last eight quarters.
- The best year-over-year quarter for Operating Income over five years was Q4 2021 (growth of 160.0%); the worst was Q1 2026 (a decline of 14.9%).
- Per Business Quant data, UTHR's Operating Income in the three quarters before Q2 2026 was $325.8 million (Q1 2026), $356.7 million (Q4 2025) and $388.5 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 1.25 Bn |
| 10 | United Therapeutics | 20.55 Bn | 10.04 Bn | 683.80 Mn | 330.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 330.80 Mn |
| Mar 31, 2026 | 325.80 Mn |
| Dec 31, 2025 | 356.70 Mn |
| Sep 30, 2025 | 388.50 Mn |
| Jun 30, 2025 | 364.50 Mn |
| Mar 31, 2025 | 382.80 Mn |
| Dec 31, 2024 | 357.70 Mn |
| Sep 30, 2024 | 343.10 Mn |
| Jun 30, 2024 | 319.90 Mn |
| Mar 31, 2024 | 356.30 Mn |
| Dec 31, 2023 | 260.10 Mn |
| Sep 30, 2023 | 327.00 Mn |
| Jun 30, 2023 | 313.40 Mn |
| Mar 31, 2023 | 284.40 Mn |
| Dec 31, 2022 | 175.60 Mn |
| Sep 30, 2022 | 314.30 Mn |
| Jun 30, 2022 | 201.80 Mn |
| Mar 31, 2022 | 288.00 Mn |
| Dec 31, 2021 | 169.80 Mn |
| Sep 30, 2021 | 228.70 Mn |
API Access
United Therapeutics Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=UTHR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "UTHR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=UTHR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();